Icon

NEOSTIGMINE METHYLSULFATE (nda203629)- (3MG/3ML (1MG/ML),5MG/10ML (0.5MG/ML),10MG/10ML (1MG/ML))

NEOSTIGMINE METHYLSULFATE FRESENIUS KABI USA
3MG/3ML (1MG/ML),5MG/10ML (0.5MG/ML),10MG/10ML (1MG/ML)
No Yes
Expired Expired
None None
None No
Neostigmine Methylsulfate, a cholinesterase inhibitor, is indicated for reversal of the effects of nondepolarizing neuromuscular blocking agents (NMBA) after surgery.
2 0 2
Total Other Developers 9
Drugs with Suitability No
3MG/3ML (1MG/ML) ** ** - - -
5MG/10ML (0.5MG/ML) ** ** - - -
10MG/10ML (1MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 2
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ** ****** **.*****'* ************ ******* *********** ** ** ** & ** ** **, ***** - ***, ****, *******,, *************, ****** ******* *** ***, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.